Qube Research & Technologies (QRT)
RUBY

Qube Research & Technologies (QRT)’s Rubius Therapeutics, Inc RUBY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,225
Closed -$17K – 3172
2022
Q3 		$17K Sell
38,225
-846
-2% -$634 ﹤0.01% 2323
2022
Q2 		$33K Sell
39,071
-19,343
-33% -$32.5K ﹤0.01% 2198
2022
Q1 		$322K Buy
58,414
+26,827
+85% +$170K ﹤0.01% 1750
2021
Q4 		$306K Buy
+31,587
New +$438K ﹤0.01% 1799

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RUBY Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 38,225 shares — an estimated $17K sold.

Qube Research & Technologies (QRT) first reported a position in RUBY in Q4 2021 and held it in 4 quarters. The position peaked at $322K in Q1 2022. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 38,225 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $17K.
  • Qube Research & Technologies (QRT) first reported a position in Rubius Therapeutics, Inc in Q4 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Rubius Therapeutics, Inc position peaked at $322K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.